ALPHACENTRIC ADVISORS LLC Aclaris Therapeutics, Inc. Transaction History

ALPHACENTRIC ADVISORS LLC portfolio value:

$0
portfolio value

ALPHACENTRIC ADVISORS LLC quarter portfolio value change:

+9.84%
quarter

Aclaris Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -68K shares -989K $15.74 0
Q4 2021 share Increase +33.33% 17K shares 71K $14.33 68K
Q3 2021 share Increase +37.84% 14K shares 268K $18 51K
Q2 2021 share Increase 0.00% 37K shares 650K $17.56 37K